X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1703) 1703
bcl-2-like protein 11 (1500) 1500
humans (1207) 1207
apoptosis (1180) 1180
proto-oncogene proteins - metabolism (1016) 1016
animals (1002) 1002
membrane proteins - metabolism (998) 998
apoptosis regulatory proteins - metabolism (947) 947
mice (750) 750
proto-oncogene proteins - genetics (699) 699
membrane proteins - genetics (693) 693
apoptosis regulatory proteins - genetics (667) 667
apoptosis - drug effects (565) 565
cell line, tumor (538) 538
bim (519) 519
cell biology (517) 517
biochemistry & molecular biology (430) 430
oncology (389) 389
proto-oncogene proteins c-bcl-2 - metabolism (353) 353
phosphorylation (337) 337
female (329) 329
expression (327) 327
proteins (319) 319
activation (291) 291
cancer (290) 290
male (255) 255
signal transduction (253) 253
apoptosis - physiology (249) 249
article (227) 227
apoptosis - genetics (222) 222
mice, knockout (221) 221
hemic and lymphatic diseases (217) 217
cells, cultured (216) 216
death (208) 208
mice, inbred c57bl (202) 202
apoptosis regulatory proteins (196) 196
proto-oncogene proteins c-bcl-2 - genetics (196) 196
survival (195) 195
bcl-2 family (194) 194
biological phenomena, cell phenomena, and immunity (194) 194
mitochondria - metabolism (191) 191
immunology (188) 188
bcl-2 (186) 186
bh3-only proteins (182) 182
cell line (181) 181
cell-death (181) 181
antineoplastic agents - pharmacology (177) 177
bcl-2-associated x protein - metabolism (172) 172
down-regulation (171) 171
gene expression (170) 170
research (170) 170
bim protein (167) 167
cell death (167) 167
bcl-2-like protein 11 - metabolism (166) 166
in-vivo (161) 161
abridged index medicus (158) 158
bax (151) 151
rna interference (148) 148
up-regulation (146) 146
mitochondria (145) 145
cell survival (144) 144
proto-oncogene proteins - physiology (143) 143
rats (142) 142
signal transduction - drug effects (142) 142
hematology (140) 140
blotting, western (137) 137
membrane proteins - physiology (137) 137
mutation (136) 136
bcl-2-like protein 11 - genetics (131) 131
cells (129) 129
apoptosis regulatory proteins - physiology (124) 124
analysis (123) 123
bcl-x protein - metabolism (123) 123
multidisciplinary sciences (123) 123
carrier proteins - metabolism (121) 121
family-member bim (119) 119
proto-oncogene proteins - biosynthesis (117) 117
cell survival - drug effects (114) 114
membrane proteins - biosynthesis (113) 113
mice, transgenic (113) 113
myeloid cell leukemia sequence 1 protein (111) 111
neoplasms (111) 111
research article (111) 111
kinases (110) 110
genetic aspects (108) 108
apoptosis regulatory proteins - biosynthesis (107) 107
caspases - metabolism (107) 107
forkhead transcription factors - metabolism (106) 106
protein binding (106) 106
reverse transcriptase polymerase chain reaction (105) 105
transfection (105) 105
induced apoptosis (104) 104
mcl-1 (104) 104
proto-oncogene proteins c-akt - metabolism (104) 104
caspase 3 - metabolism (103) 103
cell proliferation - drug effects (103) 103
flow cytometry (102) 102
membrane proteins (102) 102
gene expression regulation, neoplastic (101) 101
inhibition (99) 99
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Biochemical Journal, ISSN 0264-6021, 1760, Volume 459, Issue 3, pp. 513 - 524
BIK (BCL2-interacting killer) is a pro-apoptotic BH3 (BCL2 homology domain 3)-only protein and a member of the BCL2 protein family. It was proposed recently... 
BCL2-interacting killer (BIK) | Extracellularsignal-regulated kinase 1/2 (ERK1/2) | BCL2-interacting mediator of cell death (BIM) | Cell cycle | Apoptosis | Proteasome | Cyclin-Dependent Kinase 6 - antagonists & inhibitors | Neoplasms - metabolism | Humans | Neoplasm Proteins - antagonists & inhibitors | G1 Phase - drug effects | Neoplasm Proteins - metabolism | Proto-Oncogene Proteins - biosynthesis | Proteolysis - drug effects | Ubiquitination - drug effects | Bcl-2-Like Protein 11 | RNA Interference | Apoptosis Regulatory Proteins - genetics | Antineoplastic Agents - pharmacology | Membrane Proteins - metabolism | Gene Expression Regulation, Neoplastic - drug effects | Cyclin-Dependent Kinase 4 - antagonists & inhibitors | Neoplasm Proteins - genetics | Apoptosis Regulatory Proteins - biosynthesis | Proto-Oncogene Proteins - metabolism | MAP Kinase Kinase 1 - antagonists & inhibitors | Proto-Oncogene Proteins - antagonists & inhibitors | Proteasome Inhibitors - pharmacology | Membrane Proteins - genetics | Neoplasm Proteins - biosynthesis | Neoplasms - enzymology | Proteasome Endopeptidase Complex - chemistry | MAP Kinase Kinase 1 - metabolism | Proto-Oncogene Proteins - genetics | Cyclin-Dependent Kinase 6 - metabolism | MAP Kinase Kinase 2 - metabolism | Cyclin-Dependent Kinase 4 - metabolism | Apoptosis Regulatory Proteins - metabolism | Neoplasms - drug therapy | Membrane Proteins - biosynthesis | MAP Kinase Signaling System - drug effects | Membrane Proteins - antagonists & inhibitors | MAP Kinase Kinase 2 - antagonists & inhibitors | Protein Stability - drug effects | Apoptosis Regulatory Proteins - antagonists & inhibitors | Cell Line, Tumor | Protein Kinase Inhibitors - pharmacology | RNA, Small Interfering | Proteasome Endopeptidase Complex - metabolism | Index Medicus
Journal Article
Urologic Oncology: Seminars and Original Investigations, ISSN 1078-1439, 2012, Volume 30, Issue 5, pp. 652 - 659
Abstract Bacillus Calmette-Guerin (BCG)-refractory generated a high risk to patients with bladder cancer during treatment. Tyrosine kinase receptor (TKR) and... 
Urology | Sutent | Synergism | Combined therapy | Bacillus Calmette-Guerin (BCG) | Apoptosis | PROTEIN | ANGIOGENESIS | SUPERFICIAL BLADDER-CANCER | ALPHA | THERAPY | ONCOLOGY | UROLOGY & NEPHROLOGY | MICE | EXPRESSION | ENDOTHELIAL GROWTH-FACTOR | Apoptosis - drug effects | Humans | BCG Vaccine - pharmacology | Vascular Endothelial Growth Factor A - genetics | Dose-Response Relationship, Drug | Proto-Oncogene Proteins c-bcl-2 - metabolism | Urinary Bladder Neoplasms - genetics | Bcl-2-Like Protein 11 | Urinary Bladder Neoplasms - pathology | Indoles - pharmacology | Antineoplastic Agents - pharmacology | Membrane Proteins - metabolism | Gene Expression Regulation, Neoplastic - drug effects | Urinary Bladder Neoplasms - metabolism | Carcinoma, Transitional Cell - genetics | Proto-Oncogene Proteins - metabolism | Cell Survival - drug effects | Carcinoma, Transitional Cell - metabolism | Reverse Transcriptase Polymerase Chain Reaction | Blotting, Western | Apoptosis Regulatory Proteins - metabolism | Drug Synergism | Cell Movement - drug effects | Pyrroles - pharmacology | Carcinoma, Transitional Cell - pathology | Signal Transduction - drug effects | Cell Line, Tumor | bcl-X Protein - metabolism | Adenocarcinoma | Tyrosine | Adjuvant treatment | Antineoplastic agents | Bladder cancer | Cells | Antimitotic agents | Messenger RNA | Analysis | Vascular endothelial growth factor | Health aspects | Cancer | Index Medicus
Journal Article
The EMBO Journal, ISSN 0261-4189, 01/1998, Volume 17, Issue 2, pp. 384 - 395
Journal Article
The EMBO Journal, ISSN 0261-4189, 02/1998, Volume 17, Issue 4, pp. 1029 - 1039
Journal Article
Journal Article
Journal Article
Current Biology, ISSN 0960-9822, 10/2000, Volume 10, Issue 19, pp. 1201 - 1204
Journal Article
The American Journal of Pathology, ISSN 0002-9440, 2000, Volume 157, Issue 2, pp. 449 - 461
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 2000, Volume 106, Issue 10, pp. 1271 - 1280
Multiorgan apoptosis occurs during sepsis. Following cecal ligation and puncture (CLP) in rats, thymocytes underwent apoptosis in a time-dependent manner. C5a... 
PROGRAMMED CELL-DEATH | SIGNAL-TRANSDUCTION | MEDICINE, RESEARCH & EXPERIMENTAL | COMPLEMENT-SYSTEM | POLYMICROBIAL SEPSIS |